List view / Grid view
B&W Tek, Inc., an advanced instrumentation company that delivers lab quality Raman spectroscopy solutions through user-friendly mobile platforms, is pleased to announce its newest strategic partnership with LabWare, Inc., the global leader of Laboratory Information Management Systems (LIMS) and instrument integration software products.
3 March 2014 | By Roche
Roche announced that an independent data monitoring committee has recommended that the phase III METLung study be stopped due to a lack of clinically meaningful efficacy...
3 March 2014 | By Teva
The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults...
3 March 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities...
3 March 2014 | By AstraZeneca
AstraZeneca announced that the US Food and Drug Administration has approved the BYDUREON® Pen 2 mg as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes...
3 March 2014 | By Renishaw
Renishaw’s Raman spectroscopy team will be hosting its next Inside Raman seminar on Tuesday 8th and Wednesday 9th April 2014...
28 February 2014 | By Novartis
Novartis joins the global rare disease community in recognition of Rare Disease Day by calling for a global exchange of ideas to deepen the understanding of rare diseases and help address a significant unmet medical need...
28 February 2014 | By Merck
Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of a new, investigational tablet formulation of NOXAFIL®...
28 February 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration for Promacta™...
27 February 2014 | By kdm communications
Cresset is pleased to announce the release of our latest set of Pipeline Pilot components V2.0.0, including new tools for 3D visualization of field patterns, SAR data analysis and 3D-QSAR modeling...
27 February 2014 | By Novo Nordisk
The employees of Novo Nordisk A/S have conducted the election of employee representatives to the Board of Directors of Novo Nordisk A/S...
26 February 2014 | By Novartis
Novartis announced additional steps to extend its leadership in clinical trial data transparency...
26 February 2014 | By AstraZeneca
AstraZeneca announced the FDA approved orphan drug MYALEPT™ , which is indicated as an adjunct to diet as replacement therapy for the treatment of complications of leptin deficiency in patients with congenital or acquired generalised lipodystrophy...
26 February 2014 | By kdm communications
Tecan has launched the TouchTools™ PCR Wizard, an easy-to-use Freedom EVOware® add-on offering straightforward automation of PCR reaction set¬¬up on Freedom EVO® platforms...
25 February 2014 | By The European Medicines Agency
Over the past twelve months, a total of 12 medicines for the treatment of rare diseases were recommended for marketing authorisation by the European Medicines Agency’s Committee for Medicinal Products for Human Use...
